School of Medicine


Showing 4,061-4,080 of 4,930 Results

  • Julia Fridman Simard

    Julia Fridman Simard

    Associate Professor of Epidemiology and Population Health, of Medicine (Immunology & Rheumatology) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine)

    BioJulia Fridman Simard, ScD, is an Associate Professor of Epidemiology & Population Health, and of Medicine in Immunology and Rheumatology and Obstetrics and, by courtesy, Gynecology in Maternal Fetal Medicine at Stanford University School of Medicine.

    Dr. Simard earned her Masters and Doctorate of Science in Epidemiology degrees at the Harvard School of Public Health. During that time she trained with investigators at the Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital and the Cardiovascular Epidemiology Research Unit at Beth Israel Deaconess Medical Center. In 2008, Dr. Simard relocated to Sweden to begin a Postdoctoral Fellowship in Clinical Epidemiology at the Karolinska Institutet in Stockholm. She became an Assistant Professor in their Clinical Epidemiology Unit in 2011, and was later honored with a Karolinska Institutet Teaching Award. Leveraging the population-based registers of Sweden, Dr. Simard initiated a national register linkage study to examine the utility of registers in Systemic Lupus Erythematosus (SLE) research and develop an extensive data repository for future epidemiologic investigations.

    While maintaining a close collaboration with the Karolinska Institutet, she joined Stanford’s Epidemiology faculty in 2013. Dr. Simard studies outcomes such as malignancy, stroke, infection, and mortality, in patients with systemic autoimmune rheumatic diseases with a focus on systemic lupus erythematosus. Recently her primary research focus has shifted to the intersection between reproductive epidemiology and rheumatic disease fueled by a K01 career development award from the NIH (NIAMS) to study maternal and fetal outcomes in systemic lupus pregnancy. This led to collaborations with colleagues at Stanford, throughout the US, and abroad, and a series of projects focused on the diagnosis of preeclampsia and associated risks in pregnant women with systemic lupus. Dr. Simard was awarded a Peter Joseph Pappas Research Grant from the Preeclampsia Foundation for her lab's work examining preeclampsia risk in high-risk populations, and a McCormick Faculty Award from Stanford Medicine to take important steps towards disentangling preeclampsia from lupus nephritis. Dr. Simard is leading an international study of hydroxychloroquine in lupus pregnancy leveraging mixed methods in partnership with qualitative researchers, patients, clinicians, and epidemiologists in Sweden, Canada, and in the United States.

    In addition to these issues of misclassification in reproductive rheumatology questions, Dr. Simard's lab is also interested in how misclassification, missed opportunities, and misdiagnosis contribute to disparities in complex conditions such as systemic lupus. In addition to methodologic issues around misclassification and bias and the largely clinical epidemiology focus of her work, Dr. Simard's work examines social determinants of health and health disparities. Dr. Simard was recently awarded an R01 from NIH (NIAID) to study the role of cognitive and unconscious bias in clinical decision making for female-predominant diseases including lupus.

  • Robert Simoni

    Robert Simoni

    Professor, Biology

    Current Research and Scholarly InterestsCholesterol in biological membranes; genetic mechanisms & cholesterol production

  • Laura Simons

    Laura Simons

    Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)

    Current Research and Scholarly InterestsI am a Professor in the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine and a clinical psychologist who evaluates and treats youth presenting with chronic pain in the Pediatric Pain Management Clinic (PPMC) at Stanford Children’s Health. My program of research aims to utilize a pain neuroscience psychology approach to gain a mechanistic understanding of cognitive and affective processes in pediatric pain, perform rigorous patient-oriented research that translates targeted assessment into mechanistically informed treatment approaches for optimal clinical care and leverage the ubiquity of digital health to enhance patient access and reach. Central to these goals are projects targeting adolescence and youth adults with chronic pain that encompass defining brain signatures of threat interpretation, evaluating the efficacy of graded exposure (NCT03699007), deriving a biosignature of improvement vs. persistence of pain and disability (NCT04285112), and evaluating the impact of virtual reality on pain rehabilitation (NCT04636177). These studies along with additional work examining the journey of pain care for youth with pain and their parents form a comprehensive research portfolio in the realm of understanding and treating chronic pain in young people. My long-term career goal is to lead a robust research program focusing on alleviating the suffering of youth and emerging adults with chronic pain.

  • Robert Sinclair

    Robert Sinclair

    Charles M. Pigott Professor in the School of Engineering

    BioUsing high-resolution transmission electron microscopy, Sinclair studies microelectronic, magnetic thin film microstructure and nanomaterials.

  • Harminder Singh, MD, MBA

    Harminder Singh, MD, MBA

    Clinical Professor, Neurosurgery

    Current Research and Scholarly InterestsMinimally Invasive Cranial and Spinal Surgery, Endoscopic Keyhole Surgery

  • Kuldev Singh, MD, MPH

    Kuldev Singh, MD, MPH

    Professor of Ophthalmology

    Current Research and Scholarly InterestsGlaucoma, clinical epidemiology

  • Sundeep Singh

    Sundeep Singh

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    BioAfter living and training throughout the country, I am excited to be part of the Stanford team. As a result of both my personal experiences and training, I am passionate about ensuring that patients receive appropriate diagnostic testing and treatment options in order to improve people's quality of life. In collaboration with my amazing colleagues, I am confident in the high quality and easily accessible care we are able to provide to patients across northern California.

    While my interest is most in inflammatory bowel disease, I am also interested in the interaction between mental health, incentives, and emerging therapies in gastroenterology.

  • Upinder Singh

    Upinder Singh

    Stanford Medicine Professor of Infectious Disease and Professor of Medicine (Infectious Diseases & Geographic Medicine), Emerita

    Current Research and Scholarly InterestsOur lab elucidates the molecular basis of pathogenesis of the protozoan parasite Entamoeba histolytica. We use genetic and genomic approaches to identify novel virulence determinants and to characterize the global epidemiology of the parasite.

  • Vanila M. Singh, MD MACM

    Vanila M. Singh, MD MACM

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    BioDr Singh is the immediate past Chief Medical Officer in the US Department of Health and Human Services and was Chairperson of the highly regarded HHS Task Force in conjunction with the Department of Defense and the Veterans Affairs. She led this group to the comprehensive and approachable final report submitted to Congress. She is a clinical associate professor of Anesthesiology, Pain and Peri-operative Medicine at Stanford and is a teaching mentor at Walter Reed National Military Medical Center.

    Pain Management Best Practices HHS Task Force Report: https://www.hhs.gov/sites/default/files/pain-mgmt-best-practices-draft-final-report-05062019.pdf

    The Best Practices Pain Inter-agency report that was convened by US Department of HHS in conjunction with Department of Defense and the Veterans Administration is supported by over 160 organizations including the Human Rights Watch, dozens of patient advocacy groups, respected medical organizations including AMA, AAOS, AAPS, ASA, CMA, ASIPP, AAPM, ACOG, CSNS, and dozens of others and key stakeholders such as nursing, social workers, integrative health primary physicians pharmacists and others. There were over 10,000 public comments highlighting the challenges that forced tapering of opioids and the abandonment of chronic pain patients across the nation. The significant patient harms have been a topic of concern with the resulting number of suicides and adverse clinical outcomes pushing patients to the medically unsupervised black market.

    Dr Singh has a background in molecular and cell biology, economics, pain medicine, and regional anesthesia with a forte in advanced ultrasound guided procedures for pain and anesthesia medicine. She is double board-certified in pain and anesthesiology. She has served in medical ethics, and to served on scientific editorial boards, committees for the American Society of Regional Anesthesia, American Society of Interventional Pain Physicians, California Medical Association, and the Santa Clara County Medical Association . She has an interest & remains involved in health policy with a background in economics. Dr Singh has been invited and has spoken extensively around the country about the opioid crisis and pain management as well as the growing illicit drug crisis afflicting the nation. Dr Singh's practice uniquely focuses on regional anesthesia and peri-operative, subacute, and the development of chronic pain, with an appreciation on complimentary and traditional medicine approaches that emphasizes an individualized patient-centered approach. She has interests that include public health, persistent pain following surgical procedures, and long term chronic and complex pain issues. Dr. Singh has a background and interest in education for medical students, residents, and fellows. She has identified the growing clinical administrative burden of physicians as a challenge to good patient care, and has spoken about EHR and health IT in general. She strongly believes in a compassionate, individualized patient-centered approach to medicine. She completed a masters in academic medicine as part of her professional development to further enhance leadership, educational curriculum development, interdisciplinary work and various presentations and projects with faculty from around the country.